作者
Muzaffer Demir, Omer Iqbal, Debra A Hoppensteadt, Pietro Piccolo, Sarfraz Ahmad, Christopher L Schultz, Robert J Linhardt, Jawed Fareed
发表日期
2001/4
期刊
Clinical and Applied Thrombosis/Hemostasis
卷号
7
期号
2
页码范围
131-140
出版商
Sage Publications
简介
Heparinomimetic mannopentaose phosphate sulfate (PI-88) (Progen Industries Ltd. Brisbane, Australia), currently developed as an anticoagulant and antiproliferative agent, mainly is composed of a pentomannan. However, tetrasaccharide and disaccharide components are also present. The molecular profile and the anticoagulant potency of PI-88 are investigated in this study. Gel permeation chromatography and polyacrylamide gel electrophoresis analyses were carried out to determine the molecular profile and separation of components of PI-88, respectively. Potentiation of antithrombin III (ATIII) and heparin cofactor-II (HC-11) activity were measured using chromogenic substrate assay. In order to determine anticoagulant and antiprcatease effects of PI-88, various global anticoagulant tests, such as the prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), Hep-test …
引用总数
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202334647292524322122222
学术搜索中的文章